Dashboard
Manage Tickers

RGEN REPLIGEN CORP

Nasdaq repligen.com


$ 153.91 $ 7.78 (5.34 %)    

Tuesday, 11-Nov-2025 16:34:52 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.49 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.37 $ 2.90 (0.43 %)
TLT $ 89.91 $ 0.01 (0.01 %)
GLD $ 380.58 $ -0.09 (-0.02 %)
$ 153.44
$ 145.32
$ 153.88 x 3
$ 165.00 x 211
$ 145.32 - $ 155.13
$ 102.97 - $ 182.52
1,088,929
na
8.64B
$ 1.50
$ 4,969.65
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 03-13-2025 12-31-2024 10-K
5 11-18-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 02-17-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-27-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-hold-on-repligen-raises-price-target-to-165
Canaccord Genuity Maintains Hold on Replig...
10/29/2025 20:50:39

Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and raises the price target from $150 to ...

barclays-maintains-overweight-on-repligen-raises-price-target-to-175
Barclays Maintains Overweight on Repligen,...
10/29/2025 13:32:13

Barclays analyst Luke Sergott maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $160 to $175.

repligen-lowers-fy2025-gaap-eps-guidance-from-085-092-to-082-085-vs-091-est-raises-fy2025-sales-guidance-from-715000m-735000m-to-729000m-737000m-vs-726458m-est
Repligen Lowers FY2025 GAAP EPS Guidance f...
10/28/2025 11:31:57

Repligen (NASDAQ:RGEN) lowers FY2025 GAAP EPS guidance from $0.85-$0.92 to $0.82-$0.85 vs $0.91 analyst estimate. Raises FY2025...

repligen-narrows-fy2025-adj-eps-guidance-from-165-172-to-165-168-vs-168-est-raises-fy2025-sales-guidance-from-715000m-735000m-to-729000m-737000m-vs-726458m-est
Repligen Narrows FY2025 Adj EPS Guidance f...
10/28/2025 11:31:47

Repligen (NASDAQ:RGEN) narrows FY2025 Adj EPS guidance from $1.65-$1.72 to $1.65-$1.68 vs $1.68 analyst estimate. Raises FY2025...

repligen-q3-adj-eps-046-beats-042-estimate-sales-188805m-beat-181338m-estimate
Repligen Q3 Adj. EPS $0.46 Beats $0.42 Est...
10/28/2025 11:30:33

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 10....

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

evercore-isi-group-maintains-outperform-on-repligen-raises-price-target-to-175
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:51:20

Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target f...

barclays-maintains-overweight-on-repligen-raises-price-target-to-160
Barclays Maintains Overweight on Repligen,...
10/02/2025 13:30:44

Barclays analyst Luke Sergott maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $150 to $160.

what-8-analyst-ratings-have-to-say-about-repligen
What 8 Analyst Ratings Have To Say About R...
10/01/2025 20:01:23

hsbc-initiates-coverage-on-repligen-with-buy-rating-announces-price-target-of-150
HSBC Initiates Coverage On Repligen with B...
10/01/2025 17:22:44

HSBC analyst Yessica Sanchez initiates coverage on Repligen (NASDAQ:RGEN) with a Buy rating and announces Price Target of $150.

this-sarepta-therapeutics-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Sarepta Therapeutics Analyst Turns Bu...
09/22/2025 12:43:32

evercore-isi-group-upgrades-repligen-to-outperform-raises-price-target-to-155
Evercore ISI Group Upgrades Repligen to Ou...
09/22/2025 11:33:53

Evercore ISI Group analyst Daniel Markowitz upgrades Repligen (NASDAQ:RGEN) from In-Line to Outperform and raises the price ...

jefferies-maintains-hold-on-repligen-lowers-price-target-to-135
Jefferies Maintains Hold on Repligen, Lowe...
09/12/2025 10:20:19

Jefferies analyst Matthew Stanton maintains Repligen (NASDAQ:RGEN) with a Hold and lowers the price target from $145 to $135.

analyst-expectations-for-repligens-future
Analyst Expectations For Repligen's Future
09/03/2025 12:00:50

hc-wainwright--co-reiterates-buy-on-repligen-maintains-180-price-target
HC Wainwright & Co. Reiterates Buy on Repl...
09/03/2025 10:49:16

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Repligen (NASDAQ:RGEN) with a Buy and maintains $180 price tar...

repligen-stock-outlook-risk-skewed-to-the-downside-through-2026
Repligen Stock Outlook: Risk Skewed To The...
07/31/2025 14:45:50

Repligen stock has been in a prolonged downtrend, and Adhishthana principles suggest more weakness ahead. Here's what inves...

repligen-partners-with-novasign-to-advance-digital-twins-and-predictive-process-control-for-bioprocessing-workflows
Repligen Partners With Novasign To Advance...
07/31/2025 11:38:04

rbc-capital-maintains-outperform-on-repligen-raises-price-target-to-204
RBC Capital Maintains Outperform on Replig...
07/30/2025 14:40:27

RBC Capital analyst Conor McNamara maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $193 ...

wells-fargo-maintains-overweight-on-repligen-lowers-price-target-to-175
Wells Fargo Maintains Overweight on Replig...
07/30/2025 14:11:17

Wells Fargo analyst Brandon Couillard maintains Repligen (NASDAQ:RGEN) with a Overweight and lowers the price target from $1...

repligen-raises-fy2025-adj-eps-guidance-from-163-172-to-165-172-vs-168-est-raises-fy2025-sales-guidance-from-695000m-720000m-to-715000m-735000m-vs-709438m-est
Repligen Raises FY2025 Adj EPS Guidance fr...
07/29/2025 11:33:59

Repligen (NASDAQ:RGEN) raises FY2025 Adj EPS guidance from $1.63-$1.72 to $1.65-$1.72 vs $1.68 analyst estimate. Raises FY2025 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION